4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-012038
Director sold 7,500 shares at an average $193.00 ($1,447,516)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-16 | Sale : show line 1 in the form | −400 | $189.51 | $75,802 | 465,591 | D |
| 2021-02-16 | Sale : show line 2 in the form | −1,400 | $190.42 | $266,582 | 464,191 | D |
| 2021-02-16 | Sale : show line 3 in the form | −2,683 | $191.63 | $514,140 | 461,508 | D |
| 2021-02-16 | Sale : show line 4 in the form | −451 | $192.61 | $86,869 | 461,057 | D |
| 2021-02-16 | Sale : show line 5 in the form | −600 | $194.60 | $116,760 | 460,457 | D |
| 2021-02-16 | Sale : show line 6 in the form | −800 | $195.43 | $156,345 | 459,657 | D |
| 2021-02-16 | Sale : show line 7 in the form | −633 | $197.36 | $124,929 | 459,024 | D |
| 2021-02-16 | Sale : show line 8 in the form | −233 | $198.08 | $46,153 | 458,791 | D |
| 2021-02-16 | Sale : show line 9 in the form | −300 | $199.78 | $59,935 | 458,491 | D |
| Open-market sales · 7,500 sh · avg $193.00 · $1,447,516 | ||||||
Loading xslF345X03/doc4.xml…